Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centhaquine as an Adjuvant for Hypovolemic Shock
NCT05956418Phase 4Recruiting
- Sponsor
- Pharmazz, Inc.
- Start
- Aug 2021
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of centhaquine in hypovolemic shock, sponsored by Pharmazz, Inc.. Started Aug 2021; status: recruiting.
02
Drugs
centhaquine
03
Conditions
hypovolemic shock
Beyond the preview
Go deeper on NCT05956418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05956418.